Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (JANX)

Q: What does CUSIP 47103J105 represent in this 13F holders report?

CUSIP 47103J105 is the security identifier for JANX - Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held JANX - Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q2 2024?

153 institutional investors reported JANX - Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q2 2024. Use the holders table for investor-level position and value details.

CUSIP: 47103J105

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 44,723,442
Total 13F value: $1,873,142,325
Share change: +2,389,485
Put/Call ratio: 142%
SEC-reported price per share: $41.89
Number of holders: 153
Value change: +$107,659,314
Number of buys: 109
Number of sells: 51
Shares outstanding: 60,419,303

Security key

47103J105

Report period

Q2 2024

Institutions

153

Top holders

JANX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Janux Therapeutics, Inc. SEC filings Janux Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 47103J105

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of JANX - Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Bregua Corp

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

0/15

Latest evidence

03 Jun 2024

3/4/5 13F Highest disclosed value: $345,086,798 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $345.09M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Disclosed position value Top 5

Bregua Corp $22.01M

RA CAPITAL MANAGEMENT, L.P. $345.09M

FMR LLC $291.75M

Tighe Reardon $227.14M

ORBIMED ADVISORS LLC $160.97M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Bregua Corp	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$22,008,098 3,749,250 shares	—	15 Jun 2021
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	— denominator unverified	$345,086,798 9,165,652 shares	—	31 Mar 2024
FMR LLC	13F Company 13F	— denominator unverified	$291,750,175 7,749,009 shares	—	31 Mar 2024
Tighe Reardon	3/4/5 Acting Chief Financial Officer 3/4/5	— mixed-class rows	$227,140,231 4,305,680 shares mixed-class rows	—	03 Jun 2024
ORBIMED ADVISORS LLC	13F 3/4/5 Company · Director 13F 3/4/5	— denominator unverified	$160,974,570 4,275,553 shares	—	31 Mar 2024
BVF INC/IL	13F Company 13F	— denominator unverified	$109,931,148 2,919,818 shares	—	31 Mar 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

153

44,723,442

Rows available

153

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

118

Q2 2024 holders

153

Holder diff

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q2 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend